ABSTRACT
Increasing evidence has suggested an important role for environmental factors such as exposure to pesticides in the pathogenesis of Parkinson`s disease (PD). Because of the potential role of mitochondrial dysfunction in striatal neurodegeneration in PD, rotenone, a potent reversible competitive inhibitor of complex I, was chosen as a possible trigger of Parkinson`s-like syndrome. The loss of dopaminergic neurons in PD, besides the blockade of mitochondrial complexes, augment the formation of free radicals. Therefore, administration of the mitochondrial enhancer coenzyme Q10 (CoQ10), with its known antioxidant activity, may be promising in attenuating the case. Male Wistar albino rats (250-300 g) were allocated into a normal control group, rotenone-induced toxicity group and rotenone + CoQ10-treated group. Rotenone was injected s.c at a dose of 1.5 mg kg-1 every other day for a total of six injections. CoQ10 was administered orally at a dose of 100 mg kg-1 day -1 starting from the first day of rotenone injection and continued thereafter for a total period of 11 days. The striatal biochemical parameters were assessed 24 h after the last rotenone injection. Rotenone resulted in significant decrease in the contents of dopamine (DA), glutamate and reduced glutathione (GSH) accompanied by a marked increase in malondialdehyde (MDA) level and lactate dehydrogenase (LDH) activity. However, no change was observed in the levels of superoxide dismutase (SOD) and nitric oxide (nitrite/nitrate). CoQ10 reduced the elevated levels of MDA and LDH, while restored that of GSH. However, the activity of SOD enzyme was stimulated. In conclusion, this study indicated the role of CoQ10 in ameliorating the oxidative stress associated with PD, but it was not capable of overcoming the whole negative effects of rotenone. Therefore, new approaches besides providing antioxidants that offer neuroprotection of striatal dopaminergic neurons in PD are still in need.
PDF References Citation
How to cite this article
Hanan M. Abd-El Gawad, Dalaal M. Abdallah and Hanan S. El-Abhar, 2004. Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10. Journal of Biological Sciences, 4: 568-574.
DOI: 10.3923/jbs.2004.568.574
URL: https://scialert.net/abstract/?doi=jbs.2004.568.574
DOI: 10.3923/jbs.2004.568.574
URL: https://scialert.net/abstract/?doi=jbs.2004.568.574
REFERENCES
- Fahn, S., 2003. Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci., 991: 1-14.
CrossRef - Olanow, C.W. and W.G. Tatton, 1999. Etiology and pathogenesis of parkinson's disease. Annu. Rev. Neurosci., 22: 123-144.
PubMed - Betarbet, R., T.B. Sherer, G. MacKenzie, M.G. Osuna, A.V. Panov and J.T. Greenamyre, 2000. Chronic systemic pesticide exposure reproduces features of parkinson's disease. Nature Neurosci., 3: 1301-1306.
PubMed - Le Couteur, D.G., A.J. McLean, M.C. Taylor, B.L. Woodham and P.G. Boar, 1999. Pesticides and Parkinson's disease. Biomed. Pharmacother., 53: 122-130.
CrossRefDirect Link - Jenner, P.and C.W. Olanow, 1998. Understanding cell death in parkinson's disease. Ann. Neurol., 44: 72-84.
PubMed - Ebadi, M., S.K. Srinivasan and M.D. Bax, 1996. Oxidative stress and antioxidant therapy in parkinson's disease. Prog. Neurobiol., 48: 1-19.
CrossRef - Ferrante, R.J., J.B. Schultz, N.W. Kowall and M.F. Beal, 1997. Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not substantia nigra. Brain Res., 753: 157-162.
CrossRef - Frei, B., M.C. Kim and B.N. Ames, 1990. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Nat. Acad. Sci. USA., 87: 4879-4883.
Direct Link - Abe, K., H. Fujimura, Y. Nishikawa, S. Yorifuki and T. Mezaki et al., 1991. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurol. Scand, 83: 356-359.
CrossRef - Beal, M.F., D.R. Henshaw, B.G. Jenkins, B.R. Rosen and J.B. Schulz, 1994. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann. Neurol., 36: 882-888.
CrossRefDirect Link - Beutler, E., O. Duron and B.M. Kelly, 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61: 882-888.
PubMedDirect Link - Uchiyama, M. and M. Mihara, 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem., 86: 271-278.
CrossRefDirect Link - Marklund, S. and G. Marklund, 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47: 469-474.
CrossRefPubMedDirect Link - Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem., 193: 265-275.
CrossRefPubMedDirect Link - Heikkila, R.E., W.J. Nicklas, I. Vyas and R.C. Duvoisin, 1985. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci. Lett., 62: 389-394.
- Waterfall, A.H., G. Singh, J.R. Fry and C.A. Marsden, 1996. Acute acidosis elevates malondialdehyde in rat brain in vivo. Brain Res., 712: 102-106.
CrossRef - Dexter, D.T., C.J. Carter, F.R. Wells, F. Javoy-Agid and Y. Agid et al., 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52: 381-389.
Direct Link - Ciesielska, A., I. Joniec, A. Przybylkowski, G. Gromadzka, I. Kurkowska-Jastrzebska, A. Czlonkowska and A. Czlonkowski, 2003. Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease. Acta Neurobiol. Exp. Wars., 63: 117-126.
Direct Link - Cutillas, B., M. Espejo and S. Ambrosio, 1998. 7-Nitroindazole prevents dopamine depletion caused by low concentrations of MPP+ in rat striatal slices. Neurochem. Int., 33: 35-40.
PubMed - Thiffault, C., N. Aumont, R. Quirion and J. Poirier, 1995. Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem., 65: 2725-2733.
CrossRef - Saggu, H., J. Cooksey, D. Dexter, F.R. Wells, A. Lees, P. Jenner and C.D. Marsden, 1989. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem., 53: 692-697.
CrossRef - Marttila, R.J., H. Lorentz and U.K. Rinne, 1988. Oxygen toxicity protecting enzymes in Parkinson's disease. Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci., 86: 321-331.
CrossRef - Gsell, W., R. Conrad, M. Hickethier, E. Sofic and L. Frolich et al., 1995. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem., 64: 1216-1223.
CrossRefDirect Link - Beal, M.F., 2002. Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Res., 36: 455-460.
CrossRefDirect Link - Schulz, J.B., R.T. Matthews, D.R. Henshaw and M.F. Beal, 1996. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases. Neuroscience, 71: 1043-1048.
CrossRef - Beal, M.F., E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, J.M. Miller et al., 1993. Neurochemical and histologic characterization of excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci., 13: 4181-4192.
Direct Link - Favit, A., F. Nicoletti, U. Scapagnini and P.L. Canonico, 1992. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. J. Cerebr. Blood Flow Metab., 12: 638-645.
PubMed - Barbiroli, B., S. Lotti and R. Lodi, 1999. Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors, 9: 253-260.
PubMed - Carrillo, M.C., K. Kitani, S. Kanai, Y. Sato and G.O. Ivy, 1992. The ability of (-) deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective. Life Sci., 50: 1985-1992.
CrossRef